These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3749402)

  • 101. HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome.
    Stokes PE; Sikes C; Lasley B; Stoll P
    J Psychiatr Res; 2002; 36(6):417-21. PubMed ID: 12393311
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Hypothalamic-pituitary-adrenal axis feedback sensitivity in different states of back pain.
    Nees F; Löffler M; Usai K; Flor H
    Psychoneuroendocrinology; 2019 Mar; 101():60-66. PubMed ID: 30414593
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Serum aldosterone following dexamethasone in depressed patients.
    Targum SD; White ME; Collins-Rothe H; Sullivan P
    Psychoneuroendocrinology; 1984; 9(3):305-9. PubMed ID: 6494383
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Dexamethasone suppression in essential hypertension: effects on cortisol and blood pressure.
    Whitworth JA; Gordon D; McLachlan-Troup N; Scoggins BA; Moulds RW
    Clin Exp Hypertens A; 1989; 11(2):323-35. PubMed ID: 2706798
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Hypercortisolemia decreases dexamethasone half-life in rabbit.
    Stokes PE; Stoll PM; Schluger JH; Lasley B
    J Psychiatr Res; 2002; 36(6):423-8. PubMed ID: 12393312
    [TBL] [Abstract][Full Text] [Related]  

  • 106. HPA-axis hyperactivity and mortality in psychotic depressive disorder: preliminary findings.
    Coryell W; Fiedorowicz J; Zimmerman M; Young E
    Psychoneuroendocrinology; 2008 Jun; 33(5):654-8. PubMed ID: 18378097
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The stress hormone system is back on the map.
    Holsboer F
    Curr Psychiatry Rep; 2000 Dec; 2(6):454-6. PubMed ID: 11122996
    [No Abstract]   [Full Text] [Related]  

  • 108. Pharmacoendocrinology of major depression.
    Rubin RT
    Eur Arch Psychiatry Neurol Sci; 1989; 238(5-6):259-67. PubMed ID: 2670573
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Past and present strategies of research on the HPA-axis in psychiatry.
    Berger M; Krieg C; Bossert S; Schreiber W; von Zerssen D
    Acta Psychiatr Scand Suppl; 1988; 341():112-25. PubMed ID: 3048048
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Dexamethasone suppression test in autistic children.
    Hoshino Y; Ohno Y; Murata S; Yokoyama F; Kaneko M; Kumashiro H
    Folia Psychiatr Neurol Jpn; 1984; 38(4):445-9. PubMed ID: 6535745
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Does the dexamethasone suppression test reliably discriminate between psychotic and nonpsychotic major depression?: an exploratory analysis of potential confounds.
    Gaudiano BA; Epstein-Lubow G; Miller IW
    J Nerv Ment Dis; 2009 Jun; 197(6):395-400. PubMed ID: 19525738
    [TBL] [Abstract][Full Text] [Related]  

  • 112. HPA axis dysfunction in depression: correlation with monoamine system abnormalities.
    Mokrani MC; Duval F; Crocq MA; Bailey P; Macher JP
    Psychoneuroendocrinology; 1997; 22 Suppl 1():S63-8. PubMed ID: 9264149
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Dexamethasone suppression test for depression.
    Carroll BJ
    Adv Biochem Psychopharmacol; 1984; 39():179-88. PubMed ID: 6380223
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Value of the sleep EEG as a biological marker of depressive states. Comparison with 3 neuroendocrine tests].
    Ansseau M; Scheyvaerts M; Doumont A; Poirrier R; Demonceau G; Legros JJ; Franck G
    Rev Electroencephalogr Neurophysiol Clin; 1985 Apr; 14(4):343-9. PubMed ID: 4023361
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Opioidergic regulation of hypothalamo-pituitary-adrenal function in depression and Cushing's disease: an interim report.
    Zis AP
    Psychoneuroendocrinology; 1988; 13(5):419-30. PubMed ID: 2849776
    [No Abstract]   [Full Text] [Related]  

  • 116. Age and cortisol suppression by dexamethasone in normal subjects.
    Weiner MF
    J Psychiatr Res; 1989; 23(2):163-8. PubMed ID: 2585347
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Combined biological tests for suicide prediction.
    Coryell W; Schlesser M
    Psychiatry Res; 2007 Mar; 150(2):187-91. PubMed ID: 17289156
    [TBL] [Abstract][Full Text] [Related]  

  • 118. A corticosteroid/dopamine hypothesis for psychotic depression and related states.
    Schatzberg AF; Rothschild AJ; Langlais PJ; Bird ED; Cole JO
    J Psychiatr Res; 1985; 19(1):57-64. PubMed ID: 2859366
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Research activity at the Max Planck Institute for Psychiatry (Munich): depression in later life.
    Heuser IJ; Holsboer F
    Int Psychogeriatr; 1991; 3(1):75-8. PubMed ID: 1863710
    [No Abstract]   [Full Text] [Related]  

  • 120. Dexamethasone suppression test in affective and other psychiatric disorders.
    Shima S; Kitamura T; Shikano T; Kano S; Asai M; Itoh H
    Keio J Med; 1984 Nov; 33(4):161-5. PubMed ID: 6530873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.